The future of DexCom, a maker of medical devices, is tied to the unfortunate rise in the number of people who have diabetes. The company's G6 continuous glucose monitoring (CGM) system -- the sales of which generate the bulk of its revenue -- simplifies the life of diabetes patients by helping them keep track of their blood glucose levels in real time, eliminating the need for painful finger sticks. DexCom's G6 CGM system is associated with better health outcomes for diabetes patients.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting